| Date | Title | Description |
| 16.12.2025 | Cofactor Genomics Secures Strategic Investment From Labcorp And Ascension Ventures | Cofactor Genomics has received strategic investments from Labcorp and Ascension Ventures to accelerate nationwide expansion of its OncoPrism® immunotherapy response diagnostic and broaden patient access across U.S. cancer care networks.
The... |
| 16.12.2025 | Cofactor Genomics Receives Investment from Labcorp and Ascension Ventures | Cofactor Genomics, a St. Louis, MO-based commercial-stage diagnostics company, received an investment from Labcorp and Ascension Ventures.
The amount of the deal was not disclosed.
The company intends to use the funds to support continued e... |
| 08.01.2025 | Cofactor Genomics, Inc. Announces CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for OncoPrism, its Medicare Approved Immunotherapy Test | Chris Parker appointed CEO and Board Member
Jarret Glasscock, founder and CEO, transitions to Chief Technology Officer (CTO), Board Member, and President
ST. LOUIS–(BUSINESS WIRE)–January 8, 2025–
Cofactor Genomics, Inc., a commercial-stage... |
| 18.10.2024 | Cofactor Genomics receives Medicare coverage for OncoPrism®, a machine learning-based RNA oncology test predicting immunotherapy response | SAINT LOUIS–(BUSINESS WIRE)–October 18, 2024–
Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today that Medicare contractor Palmetto GBA has granted national coverage for Onc... |
| 12.03.2024 | iSelect: Pioneering the Future of Food, Health, and Technology | At iSelect, we recognized early on the impending crisis of diabetes, obesity, and rising healthcare costs, identifying poor nutrition as a core culprit. Since 2014, our mission has been clear: to leverage innovation in agriculture and healt... |
| 17.11.2023 | Cofactor Genomics’ Immunotherapy Predictive Diagnostic, OncoPrism, Completes Validation and Moves Into Clinical Use in Head and Neck Cancer Patients | — Twenty-five institutions collaborate with Cofactor to validate OncoPrism for use in head and neck cancer patients.
SAINT LOUIS, Mo.–(BUSINESS WIRE)–November 17, 2023–
Cofactor Genomics, the company bridging the precision medicine gap, tod... |
| 23.12.2021 | Founders at Work: 160+ историй от основателей стартапов | В прошлом году я делал подборку с историями от рускоговорящих основателей из YCombinator, недавно я поднапрягся и поискал по интернету все истории основателей на англиском языке (текст, аудио и видео). Нашел истории 160+ стартапов, рассказа... |
| 18.08.2020 | Investing with Impact Without Sacrificing Performance | Impact investing has grown up.
Originally associated with environmental and sustainability causes, the concept is now expanding to include diversity issues, social impact, healthcare and food access and more. Today, it’s about investing in ... |
| 27.05.2020 | What Will COVID-19 Mean for the Future of Healthcare? | While there is very little good to be said about the ongoing COVID-19 situation, we can only hope that we recover from this pandemic while also making the healthcare and food systems better and stronger than they were before.
Because, if th... |
| 15.07.2019 | 2 Companies That Are Working to Cure Cancer Right Now | In 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and 609,640 people died as a result of the disease, according to the National Cancer Institute. These numbers are staggering.
The challenge for clinicia... |
| 03.06.2019 | What’s health tech’s evolving role in cancer treatment? Learn more at the CONVERGE conference in Philadelphia! | Through a mix of provocative conversations, interactive networking, and a showcase of the hottest startups, you’ll get actionable insight into how AI, big data, precision medicine and more are transforming cancer treatment.
Among the highli... |
| 04.04.2019 | Solving the Public Health Crisis by Making Healthy Nutrition as Addictive as Sugar | The modern world has a serious problem with sugar.
The average American consumes more than 129 pounds of the stuff each year, according to the USDA, more than double what we ate two generations ago. And, unlike in previous decades when most... |
| 28.02.2019 | This Rare Disease Day, Let’s Do More | There are some 7,000 known rare diseases in the world today and they affect an estimated 25-30 million people in the United States alone.
This day, celebrated every year on February 28th, holds special significance to me because my six-year... |
| 08.07.2018 | Universities and legacy industries are giving rise to the Midwest’s AI startups | Even as artificial intelligence promises to transform many facets of life, the majority of AI companies in the U.S. are still concentrated in traditional tech hubs. According to a Glassdoor analysis from November, 30 percent of open jobs th... |
| 08.07.2018 | Universities and legacy industries are giving rise to the Midwest’s AI startups | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Even as artificial intelligence promises to trans... |
| 01.02.2018 | RNA Is Becoming the New DNA, Opening New Doors in Medicine | If there is one achievement that has been at the center of medical science research over the last several decades, it has been the creation of truly “personalized” medicine. These are treatments that are developed and administered on a pati... |
| 01.11.2017 | [PODCAST] Cofactor Genomics and the Future of Personalized Medicine | Subscribe: Apple Podcasts | Google Podcasts | RSS
On today’s podcast, Cofactor Genomics COO, Dr. David Messina discusses how his company is working to make personalized medicine a reality by focusing on the potential of RNA as a diagnostic ... |
| 18.09.2017 | Cofactor Genomics pulls in $18 million with the aim to save lives through RNA research | Cofactor Genomics has announced an $18 million Series A financing round led by Menlo Ventures, with participation from DCVC, Ascension Ventures, iSelect, Y Combinator, Wilson Sonsini Goodrich & Rosati and Stanford.
The startup, formulat... |
| 18.09.2017 | Cofactor Genomics Announces $18M Funding in an Oversubscribed Series-A Round to Bring RNA to Precision Medicine | - |
| 18.09.2017 | Cofactor Genomics Raises $18M in Series A Funding | Cofactor Genomics, a San Francisco, CA-based developer of a platform for RNA sequencing and expression analysis, raised $18M in financing.
The round was led by Menlo Ventures with participation from existing investor Data Collective (DCVC) ... |
| 05.04.2017 | Cofactor Genomics: RNA Is About to Make Personalized Medicine a Reality | By David Messina, PhD
This is an amazing time to be in biology.
In fact, I like to say that right now we’re in a place that’s a lot like where personal computers were in 1987. In those days, PCs were pretty limited in what they could do. Th... |
| 03.10.2016 | Fifty Years — The new Silicon Valley VC that wants to save the world AND make money | “We shall escape the absurdity of growing a whole chicken in order to eat the breast or wing, by growing these parts separately under a suitable medium. Synthetic food will, of course, also be used in the future. Nor need the pleasures of t... |
| 29.09.2016 | Hard Tech Startups | Some people think YC only funds straightforward software startups. That’s definitely not the case — YC’s largest exit to date is a self-driving car company, Cruise Automation, and we’ve funded many other hard technology companies like Gingk... |
| 22.03.2016 | David Lee is back with a new fund: Refactor Capital | David Lee, a former Google executive who for several years ran the seed-stage venture fund SV Angel, is back with his own new firm, shows an SEC filing. The outfit is called Refactor Capital and it’s apparently targeting $50 million for its... |
| 05.02.2016 | Cofactor Genomics Acquires Narus Biotechnologies | Cofactor Genomics, a Saint Louis, MO-based provider of RNA products and applications, acquired Narus Biotechnologies, a San Francisco, CA-based biomarker development company.
The amount of the deal was not disclosed.
Led by Raman Talwar, ne... |
| 18.11.2015 | How Scientists Can Thrive in the Startup World | When Dave Messina entered a graduate program for genomics in 1998, he was elated. He was taking the first steps of what could be a career at a top-tier university, working on scientific research that could impact millions of lives.
But whi... |
| 09.10.2015 | YC Digest - October 3-9 | Top Stories from the YC World — October 3 to October 9, 2015
The application deadline for our Winter 2016 class is next Tuesday, October 13. Apply now!
YC News
YC Research
Welcome Jared!
Sam Altman in conversation with Elon Musk at the... |
| 09.10.2015 | YC Digest – October 3-9 | Top Stories from the YC World — October 3 to October 9, 2015
The application deadline for our Winter 2016 class is next Tuesday, October 13. Apply now!
YC News
YC Research
Welcome Jared!
Sam Altman in conversation with Elon Musk at the... |
| 20.08.2015 | Congratulations To The YC Summer 2015 Class | This week we held Demo Day for our Summer 2015 class at the Computer History Museum in Mountain View, California. It was the 21st Demo Day event in Y Combinator’s history, with a total of 102 pitches spread across two days. Below is a list ... |
| 05.08.2015 | Cofactor Genomics (YC S15) Is Studying RNA Testing To Diagnose Disease Earlier | Cofactor Genomics is a company in our current Summer 2015 class that is developing RNA testing that could allow doctors to diagnose diseases earlier and more accurately than existing test technologies.
Cofactor Genomics was founded in St. ... |
| 31.07.2015 | YC Backs Cofactor Genomics To Pursue RNA Testing, Which Could Offer Better Diagnoses Than DNA | As part of Y Combinator’s push into computational biology and bioinformatics, the early-stage firm is backing a team that used to work on the Human Genome Project and is now experimenting with RNA testing through a startup called Cofactor G... |
| - | Cofactor Genomics | “The Leaders in RNA-Seq” |
| - | What’s health tech’s evolving role in cancer treatment? Learn more at the CONVERGE conference in Philadelphia! | Encouraging results from novel cancer treatments, as presented at ASCO, are offering new hope for cancer patients and deepening the potential of precision medicine. MedCity’s CONVERGE conference in Philadelphia June 19 will highlight how in... |
| - | YC and Hard Tech Startups | Some people think YC only funds straightforward software startups. That’s definitely not the case — YC’s largest exit to date is a self-driving car company, Cruise Automation, and we’ve funded many other hard technology companies like Gingk... |
| - | How Scientists Can Thrive in the Startup World | When Dave Messina entered a graduate program for genomics in 1998, he was elated. He was taking the first steps of what could be a career at a top-tier university, working on scientific research that could impact millions of lives.
But whi... |
